Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms.
Nisha NairG KvizhinadzeGregory T JonesR RushM KhashramJ RoakeA BlakelyPublished in: The British journal of surgery (2019)
Using New Zealand's gross domestic product per capita (about NZ $45 000 or €22 100) as a cost-effectiveness threshold, a UK-style AAA screening programme would be cost-effective in New Zealand.